Chemed Corp. Stock
Chemed Corp. Stock
Chemed Corp. gained 0.810% compared to yesterday.
Chemed Corp. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
As a result the target price of 600 € shows a positive potential of 20.48% compared to the current price of 498.0 € for Chemed Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Chemed Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Chemed Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | 0.810% | 0.000% | -5.143% | - | - | - | - |
| Amn Healthcare Svs | 1.650% | 0.000% | -12.920% | -50.051% | -26.567% | -36.923% | 7.096% |
| Select Medical Holdings | 1.950% | -0.633% | 0.641% | - | - | - | - |
| Neogenomicsinc. | -5.340% | 3.306% | -11.972% | -18.831% | -19.872% | -65.249% | - |
Comments
Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $712.00 to $697.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.
Stockholders ratified the continuation of
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the